ReadCoor Stock

ReadCoor is leading the next generation of omics by delivering the first panomic spatial sequencing platform to the global audience of researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It is accomplishing this with Fluorescent In-situ Sequencing (FISSEQ), a fundamental new technology, which simultaneously integrates high throughput sequencing and three-dimensional morphometric analysis. This uniquely powerful platform will revolutionize the next phase in understanding the panomic landscape and introduce vast new opportunities for important and meaningful clinical insight.